NCT06517017
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
- Locations
-
- Huntsman Cancer Institute at the University of Utah Salt Lake City, Utah, United States
Clinical trial condition
Lymphoproliferative Disorders
Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.
10,121 public trials
2,033 recruiting studies
Lymphoproliferative Disorders trial results
NCT06395103
- Conditions
- B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +32 more
- Locations
-
- Children's Hospital Los Angeles ( Site 1006) Los Angeles, California, United States
- Children's Hospital Colorado-Center for Cancer and Blood Disorders ( Site 1016) Aurora, Colorado, United States
- Yale New Haven Hospital ( Site 1012) New Haven, Connecticut, United States
- Johns Hopkins All Children's Hospital ( Site 1025) St. Petersburg, Florida, United States
- Conditions
- Acute Lymphoblastic Leukemia, B-ALL, Hematologic Diseases, +10 more
- Locations
-
- Children's Hospital of Los Angeles Los Angeles, California, United States
- Children's National Medical Center Washington D.C., District of Columbia, United States
- Children's Healthcare of Atlanta Atlanta, Georgia, United States
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT04972942
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Phoenix Children's Hospital Phoeniz, Arizona, United States
- Loma Linda University Children's Hospital Loma Linda, California, United States
- University of California Los Angeles, California, United States
- University of California San Francisco, California, United States
- Conditions
- B Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Phoenix Childrens Hospital Phoenix, Arizona, United States
- Banner University Medical Center - Tucson Tucson, Arizona, United States
- Arkansas Children's Hospital Little Rock, Arkansas, United States
NCT05934084
- Conditions
- Behavior, Classical Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma (DLBCL), +13 more
- Locations
-
- Ancona - AOU Ospedali Riuniti - Clinica di Ematologia Ancona, Italy
- Aviano - IRCCS Centro di Riferimento Oncologico di Aviano - Divisione di Oncologia e dei Tumori immuto-correlati Aviano, Italy
- Istituto Tumori Bari Giovanni Paolo II, U.O. di Ematologia e Terapia Cellulare Bari, Italy
- Ospedale S. Martino - UOC Oncologia Belluno, Italy
Recruiting
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
NCT04870944
- Conditions
- Brain Diseases, Brain Neoplasms, Brain Stem Neoplasms, +31 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Phoenix Childrens Hospital Phoenix, Arizona, United States
- Children's Hospital Los Angeles Los Angeles, California, United States
- Children's Hospital of Orange County Orange, California, United States
Recruiting
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
NCT04002947
- Conditions
- DLBCL, Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Recruiting
Clinical Study of C402-CD19-CAR Treatment in Subjects With Relapsed or Refractory B-cell Lymphoma
NCT06830031
- Conditions
- DLBCL, Nos Genetic Subtypes, Dendritic Cell Sarcoma, Interdigitating, Diffuse Large B-cell-lymphoma, +22 more
- Locations
-
- Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences Tianjin, China
NCT07387926
- Conditions
- Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
- Locations
-
- Novartis Investigative Site Ramat Gan, Israel
- Novartis Investigative Site Sydney, New South Wales, Australia
- Novartis Investigative Site Taipei, Taiwan